B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Integrin Alpha2beta1

298 PubMed studies analyzed · 1 RCTs · Evidence Score: 43.8

Research Domains

Integrin Alpha2beta1 has been studied across 17 research domains including 🦴 Bone & Joint, ✨ Skin & Hair, 🔬 Oncology, 🫘 Kidney, ⏳ Longevity & Aging. The primary research focus is 🦴 Bone & Joint with 54% of studies addressing this area.

Loading evidence profile...

This evidence profile for Integrin Alpha2beta1 is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.